We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Washington state regulators have awarded AbbVie an exclusive contract to help the state rid itself of Hepatitis C within the next decade—the nation’s second state to adopt a subscription payment model. Read More
Drugmakers and regulators urgently need to create a pipeline of drugs to treat the growing threat of antibiotic-resistant diseases, the World Health Organization says in a new report issued Monday. Read More
Eli Lilly on Friday pulled its sarcoma treatment Lartruvo just ahead of European regulators announcing that the antibody had failed to prove its effectiveness in a pivotal clinical trial. Read More
The FDA’s Antimicrobial Drugs Advisory Committee on Friday overwhelmingly rejected the use of the injectable antibiotic bacitracin for babies. Read More
NICE also recommended the drug as an additional treatment option for women before or during pregnancy, as well as women who are breastfeeding. Read More
PhRMA, pressed on all sides by critics of its members’ insulin-pricing policies, on Thursday made its public pitch to be part of the solution and not just the problem. Read More